CO4130215A1 - Proceso de glucosilacion de anion estereoselectivo - Google Patents

Proceso de glucosilacion de anion estereoselectivo

Info

Publication number
CO4130215A1
CO4130215A1 CO93392521A CO93392521A CO4130215A1 CO 4130215 A1 CO4130215 A1 CO 4130215A1 CO 93392521 A CO93392521 A CO 93392521A CO 93392521 A CO93392521 A CO 93392521A CO 4130215 A1 CO4130215 A1 CO 4130215A1
Authority
CO
Colombia
Prior art keywords
glucosilation
stereoselective
anion
desoxifluoro
stereoselective anion
Prior art date
Application number
CO93392521A
Other languages
English (en)
Inventor
Ta-Sen Chou
Cora Sue Grossman
Wayne Hertel Larry
Richard Elmer Holmes
Charles David Jones
Thomas Edward Mabry
Original Assignee
Eli Lilly Ando Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26721394&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CO4130215(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Eli Lilly Ando Company filed Critical Eli Lilly Ando Company
Publication of CO4130215A1 publication Critical patent/CO4130215A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06—Pyrimidine radicals
    • C07H19/073—Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/048—Pyridine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/056—Triazole or tetrazole radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/12—Triazine radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • C07H19/173—Purine radicals with 2-deoxyribosyl as the saccharide radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

EL INVENTO SE REFIERE A UN PROCESO DE GLUCOSILA- CION DE ANION ESTEREOSELECTIVO PARA PREPARAR NU- CLEOSIDOS 2´ -DESOXIFLUORO-BETA. EL CONTINUO INTERES EN LA SINTESIS DE NUCLEOSIDOS 2´ - DESOXIFLUORO Y SUS ANALOGOS ESTA BASADO EN SU UTILIZACION EXITOSA COMO AGENTES TERAPEUTICOS PARA TRATAR ENFERMEDADES VIRICAS Y CANCEROSAS.
CO93392521A 1992-06-22 1993-06-22 Proceso de glucosilacion de anion estereoselectivo CO4130215A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US90213592A 1992-06-22 1992-06-22
US4431593A 1993-04-07 1993-04-07

Publications (1)

Publication Number Publication Date
CO4130215A1 true CO4130215A1 (es) 1995-02-13

Family

ID=26721394

Family Applications (1)

Application Number Title Priority Date Filing Date
CO93392521A CO4130215A1 (es) 1992-06-22 1993-06-22 Proceso de glucosilacion de anion estereoselectivo

Country Status (19)

Country Link
US (1) US5744597A (es)
EP (1) EP0577304B1 (es)
JP (1) JPH0673086A (es)
KR (1) KR940005654A (es)
CN (1) CN1086519A (es)
BR (1) BR9302431A (es)
CA (1) CA2098874C (es)
CO (1) CO4130215A1 (es)
CZ (1) CZ123493A3 (es)
DE (1) DE69308400T2 (es)
ES (1) ES2101231T3 (es)
FI (1) FI932871A (es)
HU (1) HUT64359A (es)
IL (1) IL106078A0 (es)
MX (1) MX9303708A (es)
NO (1) NO932286L (es)
NZ (1) NZ247936A (es)
PL (1) PL299413A1 (es)
TW (1) TW234128B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4832566A (en) * 1988-02-04 1989-05-23 Westinghouse Electric Corp. Axial flow elastic fluid turbine with inlet sleeve vibration inhibitor
US5637688A (en) * 1994-12-13 1997-06-10 Eli Lilly And Company Process for preparing 1-(2'-deoxy-2'-difluoro-d-ribofuranosyl)-4-aminopyrimidin-2-one hydrochloride
CA2171518A1 (en) * 1995-03-24 1996-09-25 Douglas Patton Kjell Process for the preparation of 2,2'-anhydro- and 2' -keto-1-(3', 5'-di-o-protected-.beta.-d-arabinofuranosyl) nucleosides
US5633367A (en) * 1995-03-24 1997-05-27 Eli Lilly And Company Process for the preparation of a 2-substituted 3,3-difluorofuran
GB9525606D0 (en) * 1995-12-14 1996-02-14 Iaf Biochem Int Method and compositions for the synthesis of dioxolane nucleosides with › - configuration
DK1261350T3 (da) * 2000-02-18 2006-11-13 Southern Res Inst Fremgangsmåder til syntetisering af 2-chlor-9-(2-deoxy-2-fluor-beta-d-arabinofuranosyl)-9H-purin-6-amin
US6680382B2 (en) 2001-08-02 2004-01-20 Ilex Products, Inc. Process for preparing purine nucleosides
US7528247B2 (en) * 2001-08-02 2009-05-05 Genzyme Corporation Process for preparing purine nucleosides
US6884880B2 (en) * 2002-08-21 2005-04-26 Ash Stevens, Inc. Process for the preparation of 9-β-anomeric nucleoside analogs
US7214791B2 (en) * 2004-07-01 2007-05-08 Shenzhen Hande Technology Co., Ltd. Method for preparation of 2′-deoxy-2′, 2′-difluoro-β-cytidine or pharmaceutically acceptable salts thereof by using 1,6-anhydro-β-d-glucose as raw material
AU2005265494B2 (en) * 2004-07-29 2009-01-08 Hanmi Science Co., Ltd. 1-alpha-halo-2,2-difluoro-2-deoxy-D-ribofuranose derivatives and process for the preparation thereof
CN101076535A (zh) * 2004-12-08 2007-11-21 西科尔公司 二氟核苷及其制备方法
WO2006070985A1 (en) 2004-12-30 2006-07-06 Hanmi Pharm. Co., Ltd. METHOD FOR THE PREPARATION OF 2#-DEOXY-2#,2#-DIFLUOROCYTIDINE
CN101010329B (zh) * 2004-12-30 2011-06-08 韩美控股株式会社 2’-脱氧-2’,2'-二氟胞苷的制备方法
MX2007010316A (es) * 2005-03-04 2008-02-19 Dabur Pharma Ltd Intermediario de 21-desoxi, 21,21-difluoro-d-ribofuranosil nucleosidos enriquecidos en (-anomero y proceso para prepararlo.
CN100391966C (zh) * 2005-06-17 2008-06-04 华东师范大学 一种2’-脱氧-2’，2’-二氟-胞苷合成的方法
AT502221A1 (de) * 2005-07-20 2007-02-15 Pharmacon Forschung & Beratung Gmbh Homogemcitabine, verfahren zu ihrer herstellung sowie deren verwendung
KR100846143B1 (ko) 2007-02-28 2008-07-14 (주) 유일팜테크 2'-데옥시-2',2'-디플루오로시티딘의 전구체 및 그의제조방법
US7994310B2 (en) 2007-03-23 2011-08-09 Dongwoo Syntech Co., Ltd. Process for preparing 2′-deoxy-2′, 2′-difluorocytidine
US8193339B2 (en) * 2007-11-06 2012-06-05 Pharmaessentia Corp. Synthesis of β-nucleosides
US9790252B2 (en) 2009-07-01 2017-10-17 Cornell University 2-fluorinated riboses and arabinoses and methods of use and synthesis

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3282921A (en) * 1964-06-04 1966-11-01 Syntex Corp Halo-deoxynucleosides and processes for the preparation thereof
US4096324A (en) * 1975-07-07 1978-06-20 The Upjohn Company Cytidine nucleoside compound
DE2628202A1 (de) * 1976-06-23 1977-12-29 Max Planck Gesellschaft Verfahren zur herstellung von 2'-substituierten-d-ribofuranosylpurinderivaten
US4211773A (en) * 1978-10-02 1980-07-08 Sloan Kettering Institute For Cancer Research 5-Substituted 1-(2'-Deoxy-2'-substituted-β-D-arabinofuranosyl)pyrimidine nucleosides
FR2531962B1 (fr) * 1982-08-17 1986-11-14 Sandoz Sa Nouveaux derives de la desoxyuridine, leur preparation et leur utilisation comme medicaments
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4625020A (en) * 1983-11-18 1986-11-25 Bristol-Myers Company Nucleoside process
CA1295998C (en) * 1985-07-29 1992-02-18 Sai P. Sunkara Nucleosides and their use as antineoplastic agents
US4751221A (en) * 1985-10-18 1988-06-14 Sloan-Kettering Institute For Cancer Research 2-fluoro-arabinofuranosyl purine nucleosides
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
EP0339161A1 (en) * 1988-04-01 1989-11-02 Merrell Dow Pharmaceuticals Inc. Novel fluorophosphonate nucleotide derivatives
JPH0232093A (ja) * 1988-06-08 1990-02-01 Merrell Dow Pharmaceut Inc 抗レトロウィルスジフルオロ化ヌクレオシド類
JPH0217199A (ja) * 1988-07-05 1990-01-22 Japan Tobacco Inc ２’−デオキシ−β−アデノシンの製造方法
GB8816345D0 (en) * 1988-07-08 1988-08-10 Hoffmann La Roche Purine derivatives
HU906976D0 (en) * 1989-11-13 1991-05-28 Bristol Myers Squibb Co Process for producing 2', 3'-didesoxy-2'-fluoarabinonucleoside analogues
US5817799A (en) * 1990-07-23 1998-10-06 The United States Of America As Represented By The Department Of Health And Human Services 2'-Fluorofuranosyl derivatives and methods for preparing 2'-fluoropyrimidine and 2'-fluoropurine nucleosides
US5371210A (en) * 1992-06-22 1994-12-06 Eli Lilly And Company Stereoselective fusion glycosylation process for preparing 2'-deoxy-2',2'-difluoronucleosides and 2'-deoxy-2'-fluoronucleosides

Also Published As

Publication number Publication date
EP0577304A1 (en) 1994-01-05
CZ123493A3 (en) 1994-02-16
NO932286L (no) 1993-12-23
CN1086519A (zh) 1994-05-11
TW234128B (es) 1994-11-11
ES2101231T3 (es) 1997-07-01
DE69308400D1 (de) 1997-04-10
CA2098874C (en) 2004-04-20
FI932871A0 (fi) 1993-06-21
MX9303708A (es) 1994-05-31
JPH0673086A (ja) 1994-03-15
IL106078A0 (en) 1993-10-20
NZ247936A (en) 1995-05-26
FI932871A (fi) 1993-12-23
HUT64359A (en) 1993-12-28
PL299413A1 (en) 1994-03-07
HU9301823D0 (en) 1993-09-28
CA2098874A1 (en) 1993-12-23
BR9302431A (pt) 1994-01-11
NO932286D0 (no) 1993-06-21
DE69308400T2 (de) 1997-07-10
KR940005654A (ko) 1994-03-22
US5744597A (en) 1998-04-28
EP0577304B1 (en) 1997-03-05

Similar Documents

Publication Publication Date Title
CO4130215A1 (es) Proceso de glucosilacion de anion estereoselectivo
DE69333109D1 (de) Therapeutische nukleoside
BR8302318A (pt) Ativador de plasminogenio de tecido humano,seguencia de dna,vetor de expressao replicavel,plasmideo,microorganismo ou cultura celulor,composicao,uso do dito ativador,processo de expressao,e processo para produzir t pa humano
ES2122964T3 (es) Sitio de union de icam-1 para mac-1.
DE69415535D1 (de) Verfahren zur regulierung der sexuellen reaktion beim menschen
EP0721340A4 (en) USE OF MOLECULES TARGETED ON THE CELL SURFACE RECEPTOR TO TREAT VIRAL DISEASES
ES2060883T3 (es) Procedimiento de obtencion del acido carnosico.
ES2184970T3 (es) Utilizacion de derivados de la melatonina para la despigmentacion de la piel y composiciones que las comprenden.
BR8600857A (pt) Processo para a obtencao de couros ou peles impermeaveis
ES526873A0 (es) Procedimiento de obtencion de composiciones para promover el trofismo de la piel y de foliculos piliferosos relacionados
DE3873855D1 (de) Mischung von cholecalciferol-derivaten fuer die behandlung von nierenbezogenen knochenkrankheiten.
PT68733A (en) Process for preparing therapeutic agents which are derivatives of quinazoline
ES2056180T3 (es) Nuevos derivados de 2'-halometiliden, 2'-eteniliden y 2'-etinil citidina.
NO953878L (no) Umettede fosfonatderivater av puriner og pyrimidiner
AU2315288A (en) Cell growth inhibitors and methods of treating cancer and cell proliferative diseases
AR217578A1 (es) Procedimiento para la preparacion de 6,7-dialcoxi-1-piperidinoftalazinas,utiles como agentes terapeuticos
KR900700495A (ko) 치료제로서 유용한 치환된 아데닌 유도체
DE3065495D1 (en) Nose clip for the prophylactic or therapeutic treatment of cattle
ES288234Y (es) Dispositivo para el tratamiento estetico de la piel
EP0417003A3 (en) Use of antiprogestomimetics for stimulating ovulation
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
DE2860251D1 (en) Process for the preparation of olefinic unsaturated aliphatic or cycloaliphatic hydrocarbons
MX9204788A (es) Proceso para la produccion de curtido o recurtido mineral de cuero o piel
GR861342B (en) Process for the in vitro immunization of human splenocytes against tumor associated antigens
ES547658A0 (es) Procedimiento de preparar agentes cosmeticos para el trata- miento de la piel